Rehydration OSAL's Welcome Social
2026-02-04 19:00 UTC | Jesus College Bar, Turl Street, Oxford, OX1 3DW
Join us for our first social of the year to get to know members of the society and what other events we have in store this term!

Genflow Biosciences: Translating longevity research to the bedside
2026-02-16 18:00 | David Smith Lecture Theatre Department of Pharmacology Mansfield Road Oxford OX1 3QT United Kingdom, David Smith Lecture Theatre Department of Pharmacology Mansfield Road, Oxford United Kingdom, OX1 3QT, United Kingdom
Dr. Eric Leire is the Founder and CEO of Genflow Biosciences, a longevity gene therapy company listed on the London Stock Exchange. An MD and MBA (HEC/Kellogg), he combines research experience from the Harvard AIDS Institute with executive leadership at Pfizer and Biofund Venture Capital. Dr. Leire has guided multiple biotech companies to public listings (Nasdaq) and holds several pharmaceutical patents.

Early detection for dementia, an oxymoron? Examining the evidence from population studies
2026-03-10 18:00 | David Smith Lecture Theatre, Department of Pharmacology, Mansfield Road, Oxford OX1 3QT, David Smith Lecture Theatre, Department of Pharmacology, Mansfield Road,, Oxford, OX1 3QT
We’re delighted to invite you to an in‑person OSAL event with Professor Carol Brayne, one of the leading public health voices in dementia and ageing.
Early detection for dementia is often treated as an obvious good: find it earlier, fix it earlier. In this talk, Professor Brayne will challenge that simple narrative, drawing on decades of population‑based research to ask when dementia really becomes detectable, what “early” labels actually tell us about the future, and how screening can both help and harm.
She will explore:

How dementia trends have changed over time in real‑world populations
Why mild memory problems and “preclinical” labels do not always progress to dementia
The gap between tests/biomarkers and people’s lived cognitive function
The ethical and practical dilemmas of telling people they are “at risk” years before symptoms may—or may not—develop

What do epigenetic clocks teach us about ageing and longevity?
2026-03-17 18:00 | Rhodes Trust Lecture Theatre, Oxford, OX11HP
We’re delighted to invite you to an in‑person event with Professor Steve Horvath, one of the world’s most influential ageing researchers and a principal investigator at Altos Labs. This event is co-hosted by the Oxford Society of Ageing and Longevity(OSAL) and the Consumer, Media and Lifestyle OBN at Saïd Business School.
The development of DNA methylation-based epigenetic clocks has revolutionized our ability to measure biological age across tissues and species. In this talk, Professor Horvath will synthesize insights from his foundational clocks, such as PhenoAge and GrimAge, to discuss what they reveal about individual ageing trajectories and how lifestyle, environment, and chronic disease accelerate biological ageing. He will also rigorously address the promise and limitations of these tools as surrogate endpoints in translational geroscience and anti-ageing clinical trials.
